Prescription drug price transparency provisions modified. Proposed changes: (13) if the prescription drug was acquired by the manufacturer during the previous
12-month period, all of the following information:
(i) price at acquisition;
(ii) price in the calendar year prior to acquisition;
(iii) name of the company from which the drug was acquired;
(iv) date of acquisition; and
(v) acquisition price.